newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Reports First Quarter 2022 Financial Results and Recent Highlights

- $130 Million in Non-Dilutive Capital Strengthened Financial Position - - Presentations at Upcoming ASGCT Annual Meeting Include First-Time Details of Mechanism of Action of Nuclease-Free Gene Editing Candidate HMI-103 for PKU; Symposium to Feature L